Cancer Letters
Volume 241, Issue 1 , Pages 118-123, 8 September 2006

Role of bone morphogenetic proteins in transitional cell carcinoma cells

  • Isaac Yi Kim

      Affiliations

    • Division of Urologic Oncology, The Cancer Institute of New Jersey, 195 Little Albany Street #4560, New Brunswick, NJ 08903, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 732 235 5184.
    • ,
  • Seong Jin Kim

      Affiliations

    • Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, MD, USA

Received 26 September 2005; received in revised form 8 October 2005; accepted 10 October 2005.

Abstract 

Bone morphogenetic proteins (BMPs) are pleiotropic growth factors that signal through an interaction with the membrane receptors—type-IA, -IB, and -II (BMP-RIA, -RIB, and -RII, respectively). Although the prototypical members of this group of growth factors were isolated as osteoinductive factors, recently accumulated data have suggested that these factors regulate malignant cells. Herein, we review the data concerning BMPs in transitional cell carcinoma cells.

Keywords: Bone morphogenetic proteins (BMPs), BMP receptor, Transitional cell carcinoma (TCC), Bladder TCC cell line

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(05)00919-5

doi:10.1016/j.canlet.2005.10.009

Cancer Letters
Volume 241, Issue 1 , Pages 118-123, 8 September 2006

Article Tools

* Image Usage & Resolution